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Abstract
Glucose-6-phosphate dehydrogenase-deleted embryonic
stem (ES) cells (G6pdD) proliferate in vitro without special
requirements, but when challenged with oxidants fail to
sustain glutathione disulphide reconversion to reduced
glutathione (GSH), entering a condition of oxidative stress.
Here, we investigate the signalling events downstream of GSH
oxidation in G6pdD and wild-type (wt) ES cells. We found that
G6pdD ES cells are very sensitive to oxidants, activating an
apoptotic pathway at oxidant concentrations otherwise
sublethal for wt ES cells. We show that the apoptotic pathway
activated by low oxidant concentrations is accompanied by
mitochondria dysfunction, and it is therefore blocked by the
overexpression of Bcl-XL. Bcl-XL does not inhibit the decrease
in cellular GSH and reactive oxygen species formation
following oxidant treatment. We also found that oxidant
treatment in ES cells is followed by the activation of the MEK/
extracellular signal-regulated kinase (ERK) pathway. Interest-
ingly, ERK activation has opposite outcomes in G6pdD ES
cells compared to wt, which has a proapoptotic function in the
first and a prosurvival function in the latter. We show that this
phenomenon can be regulated by the cellular GSH level.
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Introduction
Apoptosis is a genetically programmed form of cell death that
ends in the complete disassembly of the main cellular
structures through the activation of a family of cysteine
proteases, the caspases. Activation of caspases is generally
the result of a complex integration of death-inducing signals
and survival signals, where the control of mitochondrial
integrity has been shown to play a central role.1–3 Cell death
by apoptosis can be triggered by a variety of different stimuli,
ranging from a developmental stimulus to the detection of an
unsustainable amount of DNA damage. One of the major
threats to the life of cells is represented by atmospheric
oxygen. Evolutionary adaptation to life in an oxidant atmo-
sphere represented a big achievement in the efficiency of
bioenergy production, but at the same time a serious threat for
life itself. Cells were required to learn that the oxygen should
be ‘handled with care’ in order to avoid irreversible damage to
most of the cellular components. To be able to cope with the
highly reactive oxygen species (ROS), the main side effect of
life in an oxidant atmosphere, cells therefore had to evolve an
efficient antioxidant defence capability. Oxidative stress
occurs in the cell when the antioxidant defence cannot keep
pace with the rate at which ROS are generated. The response
of the cell to oxidative stress can be very different, depending
on the intensity of the stress and its duration, and goes from
the stimulation of cell proliferation to cell cycle arrest, to cell
death by apoptosis or necrosis.4,5
The source of oxidant generation can be external to the cell
or the side product of normal aerobic metabolism. In all cases,
cells respond to the redox imbalance by producing more
reducing power. The most abundant and readily available
reducing power molecules are glutathione (GSH) and the
phosphorylated form of the reduced nicotinamide adenine
dinucleotide (NADPH). These two molecules are strictly
interdependent, given that glutathione reductase, the enzyme
responsible for the recycling of the oxidised form of GSH
(glutathione disulphide, GSSG), uses NADPH as a cofactor.
NADPH is also used as a cofactor by catalase, another
antioxidant enzyme that converts hydrogen peroxide (H2O2)
into water and oxygen.6
The establishment of a condition of oxidative stress has
been implicated in the process of ageing and as the main
cause of several human age-related degenerative diseases,
including neurodegenerative disorders, like Parkinson and
Alzheimer,7 the genesis of type II diabetes,8 heart failure and
stroke.9 At the cellular level, production of ROS affects various
signal transduction pathways and redox-responsive transcrip-
tion factors. A large number of mitogen-activated protein
kinases (MAPK) signalling pathways are involved in coordi-
nating the response to ROS formation, therefore influencing
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cell destiny. MAPKs encompass a large number of serine/
threonine kinases involved in regulating a wide array
of cellular processes including proliferation, differentiation,
stress adaptation and apoptosis.10 The extracellular signal-
regulated kinase (ERK), c-Jun N-terminal kinases (JNK)
and p38 MAPK subfamilies have all been shown to be
activated in response to oxidant injury, and therefore
could potentially contribute to influencing survival or apoptosis
following oxidative insults.11 Although the ERK pathway
was initially described to be unresponsive to stress stimuli, it
is now clear that oxidative stress can lead to substantial
activation of ERK in some cases, and that growth factor
receptors play an important role in mediating this effect. A
number of studies carried out on a variety of cell types and
diverse model agents demonstrated that elevated ERK
activity enhanced survival of cells treated with oxidants.
However, other studies using different model systems
suggest that ERK activation can contribute to apoptosis in
response to oxidant injuries.5,12
Glucose 6-phosphate dehydrogenase (G6PD) is the first
and rate-limiting enzyme of the pentose phosphate pathway
(PPP), which catalyses the oxidation of glucose-6-phosphate
to glucono-d-lactone-6-phosphate, concomitantly producing
NADPH. This pathway represents an alternative shunt for
glucose catabolism downstream of glucose phosphorylation.
The choice between glucose oxidation through the glycolitic
pathway, or its channelling into the alternative shunt of the
PPP, depends on the conditions in which the cell grows, as
well as on specific metabolic requirements.6 Although mouse
embryos deleted of the G6PD enzyme fail to develop
normally,13 we and others have shown that G6pd-deleted
embryonic stem (ES) cells can grow without particular
requirements under normal tissue culture conditions.14,15
However, if the cells are challenged with oxidants, they fail to
sustain GSSG reconversion to GSH, underlying a central role
for NADPH production in GSH homeostasis.15 In this paper,
we show that, after oxidant treatment, G6pd-deleted (G6pdD)
ES cells enter into a condition of oxidative stress that strongly
increases the level of cellular ROS and activates a cell death
pathway with all the features of a mitochondria-dependent
apoptotic pathway. Furthermore, we show that activation of
the ERK kinase plays a central role in the signalling events
downstream of the GSH/GSSG imbalance, establishing the
fate of the cell in terms of life and death.
Results
Targeted deletion of the G6pd gene sensitises ES
cells to the apoptotic and necrotic effect of
oxidants
We have recently generated, by homologous recombination,
ES cells deleted of the gene coding for G6pd (G6pdD) and
shown that diamide (Dia), a sulphidryl group oxidising agent,
drastically decreases G6pdD ES cell viability. 15 To investi-
gate the features of this loss of viability, wild-type (wt) and
G6pdD ES cells were challenged with a 30 min oxidative burst
using increasing concentrations of Dia. After 8 h, cells were
collected and analysed for markers of apoptosis. As shown in
Figure 1a, both caspase-3 and poly(ADP-ribose) polymerase
(PARP) appear to be cleaved at Dia doses as low as 100mM in
G6pd-deleted cells. A similar level of caspase-3 activation
was evident in wt ES cells only at Dia concentrations eight-fold
higher. Interestingly, the amount of caspase-3 and PARP
cleavage seemed to be increased by an increased Dia dose,
but only up to 300mM concentration (Figure 1a). A further
increase had the opposite effect, resulting in poor or null
caspase-3 activation, although the cells completely detached
from the cell culture dish and became permeable to the
Trypan blue dye (Figure 1b). This suggests that G6pdD ES
cells activate an apoptotic pathway if triggered with a relatively
low oxidative pulse, but become necrotic if the oxidative power
reaches a certain threshold.
Diamide is a thiol oxidant that rapidly oxidises GSH to
GSSG.16 This creates a redox imbalance inside the cell,
because GSH represents the most abundant source of readily
available reducing power. On the other hand, Dia has been
shown to interfere with other cellular processes, like initiation
of protein synthesis.16,17 In order to investigate if the apoptotic
effect of low Dia doses on G6pdD ES cells was due to redox
imbalance or to other redox-unrelated effects, we studied the
effect of the GSH precursor N-acetyl-cysteine (NAC) on the
apoptosis induced by Dia, arguing that an increase in the GSH
pool would titrate down a possible redox-related Dia effect. As
shown in Figure 2, G6pdD ES cells are completely protected
from Dia-induced apoptosis in the presence of 1 mM NAC.
Moreover, the oxidant sensitivity of G6pdD ES cells was
completely reverted to wt levels when they were stably
transfected with an expression vector containing the cDNA
encoding for mouse G6pd under the control of the -actin
promoter (G6pdDpG6pd) (Figure 2, lane 4).
Figure 1 ES cells deleted of the G6pd gene are extremely sensitive to Dia
treatment. (a) Wt or G6pdD were incubated with different concentrations of Dia
for 30 min. After 8 h, total proteins were extracted and separated on SDS-PAGE,
and their respective content in cleaved PARP and caspase-3 were analysed by
Western blotting. (b) ES cells, treated as in (a), were analysed for their ability to
incorporate the cell-permeable dye Trypan blue. The percentage of Trypan blue-
positive cells was calculated over the total number of cells and plotted against the
concentration of Dia
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The extreme sensitivity to apoptosis of G6pdD ES
cells is specific for oxidative insults
GSH metabolism is intimately linked to the rate of NADPH
production, because NADPH is used by glutathione reductase
to regenerate GSH from its oxidised form, GSSG. In order to
study the importance of G6PD-mediated NADPH production
on the cellular protection from redox imbalance, we studied
the effect of oxidants, other than Dia, on the viability of G6pdD
ES cells. In particular, we focused on H2O2, by itself an ROS
acting at the cytoplasmic level, and on menadione (Mq), a
quinone compound that induces the production of mitochon-
drial superoxide radicals. In order to have more reproducible
concentrations of H2O2 in the cell culture medium, we used
glucose oxidase (Gox), an enzyme that produces H2O2 from
glucose and water. As shown in Figure 3, G6pdD ES cells are
extremely sensitive, compared with wt ES cells, to both Gox
and Mq. Again, as observed with Dia, this effect was reverted
by the reintroduction of G6pd or by the presence of NAC (data
not shown).
We have shown that G6pdD ES cells undergo programmed
cell death when triggered with doses of oxidants otherwise
sublethal for wt ES cells. This observation could possibly be
explained by invoking a general increased sensitivity to
apoptosis given by the absence of G6PD activity. To
investigate if G6pdD ES cells show an increased sensitivity
to apoptosis, we treated wt and G6pd-deleted ES cells with
different apoptotic insults. As shown in Figure 3, the DNA-
damaging agents UV and cisplatin (CisPt) induced a compar-
able level of cell death in both wt and G6pd-deleted ES cells. A
similar result was observed with cycloheximide (Chx). This
was not due to a saturating amount of the agents used,
because the same result was obtained over a large range of
doses of the tested stimuli (data not shown). These data
clearly support a specific role for G6PD in the defence against
oxidative stress-causing agents, although a role in the
protection from apoptotic insults not tested cannot be
excluded.
Diamide-induced apoptosis proceeds through a
mitochondria-dependent apoptotic pathway
In most of the signal transduction pathways that lead to
apoptotic cell death, an early marker of the engagement of the
apoptotic machinery is represented by the release of
cytochrome c from the mitochondrial intermembrane space
into the cytosol. Therefore, we analysed if the apoptotic
pathway triggered by Dia in G6pdD ES cells involved
mitochondria dysfunction, by studying cytochrome c redis-
tribution following the apoptotic stimulus. Figure 4a shows that
after Dia treatment, G6pdDES cells release cytochrome c into
the cytosol in a time-dependent manner, probably as a
consequence of lost mitochondrial permeability. Cytochrome
c release was followed by the activation of caspase-9,
Figure 3 G6pdD ES cells show an increased sensitivity to the apoptotic effect
of oxidants, more than to apoptosis in general. Wt and G6pdD ES cells were
treated with Dia, Gox, Mq, Chx, CisPt and UV light as described in Materials and
methods. Apoptosis was measured by determining the amount of cytoplasmic
DNA–histone complexes using the commercial Cell Death Elisa kit (Roche)
Figure 4 Dia-induced apoptosis in G6pdD ES cells proceeds through the
mitochondrial pathway. (a) G6pdD ES cells were treated with 150mM Dia for
30 min and then collected at the indicated time points. Cytosolic fractions were
analysed by Western blot for the presence of cytochrome c or for the cleavage of
caspase-9. (b) G6pdD and G6pdDpBclXL ES cells were treated for 30 min with
150 mM Dia. After 8 h, cells were harvested and extracts were analysed by
Western blotting for PARP and caspase-3 cleavage
Figure 2 Reintroduction of the G6pd gene or treatment with the antioxidant
NAC protects G6pdD ES cells from the apoptotic effect of Dia. G6pdD and
G6pdDpG6pd ES cells were treated for 30 min with 150mM Dia in the presence or
absence of the antioxidant NAC. After 8 h, cells were harvested and extracts
were analysed by Western blotting for PARP and caspase-3 cleavage
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presumably through the induction of the apoptosome forma-
tion.
Bcl-XL is considered to be a general regulator of mitochon-
drial homeostasis, and protects from essentially most of the
apoptotic triggers. As Dia induced an apparent mitochondria
dysfunction, assayed by detecting of cytochrome c release,
we addressed the possibility that G6pdD ES stably trans-
fected with an expression vector containing the cDNA
encoding for Bcl-XL under the control of the -actin promoter
(G6pdDBclXL ) could be protected from oxidant-induced
apoptosis. When the cells were triggered with 150 mM Dia,
Bcl-XL-expressing G6pdD ES cells showed a complete
protection from the apoptotic effect of the Dia, as suggested
by the absence of caspase-3 and PARP cleavage (Figure 4b).
Diamide treatment increases cellular ROS in
G6pdD ES cells, independent of Bcl-XL expression
We have previously shown that G6pdD ES cells triggered with
low doses of Dia fail to re-establish a correct ratio of cellular
GSH/GSSG.15.GSH metabolism is tightly linked to ROS
scavenging. In fact, glutathione peroxidase catalyses the
conversion of H2O2 into water using the reducing power of
GSH. Furthermore, other forms of ROS, namely, mitochon-
drial or cytosolic superoxide anions, can be ultimately
neutralised by cellular GSH through their conversion to
H2O2, mediated by superoxide dismutase (SOD) 1 and 2.
Low levels of cellular GSH could therefore be accompanied by
an increase in the intracellular concentration of ROS. We
made use of ROS-sensitive fluorescent probes to detect the
amount of ROS generated by the treatment with 150 mM Dia of
both wt ES cells and G6pdD ES cells, transfected with an
expression vector encoding for Bcl-XL. As expected, Dia
treatment produced an appreciable increase in cellular ROS
only in G6pdD ES cells (Figure 5). Interestingly, G6pdD ES
cells showed an increased basal ROS content compared to wt
ES cells. Forced expression of Bcl-XL completely abolished
Dia-induced death, but did not prevent the production of
cellular ROS. Bcl-XL, therefore, would act downstream of
ROS production in the apoptotic pathway triggered by low
doses of Dia in G6pdD ES cells. In agreement with this, also
basal levels of ROS in G6pdD ES cells were not influenced by
Bcl-XL expression.
Different from JNK and p38 SAPKs, ERK activation
reflects the oxidative stress sensitivity of G6pdD
with respect to wt ES cells
The data presented here suggest that ES cells respond
specifically to a proapoptotic signal transduction pathway that
senses a drop in the GSH/GSSG ratio. The amount of GSH
oxidant needed to reach a GSH/GSSG ratio capable of
triggering this pathway might depend on the NADPH-
producing capability of the cell. Cellular redox imbalance
caused by altered GSH metabolism was shown to be sensed,
in other cell systems, by specific MAPK pathways.4,5 In order
to study the activation status of MAPK pathways in response
to Dia in ES cells, we used antibodies raised against
phosphorylated ERK, JNK and p38. As expected, treatment
of wt and G6pdD ES cells with different concentrations of Dia
markedly resulted in the activation of different MAPK path-
ways (Figure 6). JNK 1/2 were found to be phosphorylated
using 50mM Dia in G6pdD and 100mM Dia in wt ES cells.
Similarly, p38 showed exactly the same activation profile
as JNK1/2 in wt and G6pdD ES cells. As shown in Figure 1a,
these two oxidant concentrations do not correlate with the
induction of apoptosis either in G6pdD or in wt ES
cells. Interestingly, ERK 1/2 activation profile was strikingly
different between wt and G6pdD ES cells. In wt cells,
phosphorylated ERK 1/2 could be detected at 500mM Dia,
while in G6pdD ES cells, a 10-fold lower concentration of Dia
was sufficient (Figure 6). Therefore, ERK activation reflected
the difference in oxidative stress sensitivity between wt and
G6pdD ES cells.
Inhibition of MEK/ERK activation decreases Dia-
induced apoptosis in G6pdD, but not wt in ES cells
Activation of MAPK pathways following oxidative stress has
been shown to produce different outputs. According to the
intensity and persistence of the stimulus, they can either
increase the survival potential of cells by inducing the
transcription of several antioxidant enzymes or determine
cell death through mechanisms in part still to be elucidated.4,5
Figure 5 Treatment of G6pdD ES cells with Dia is accompanied by the
production of cellular ROS. Production of cellular ROS in the presence of 150 mM
Dia was quantified after 30 min using the ROS-sensitive fluorescent probe 20, 70-
dichlorofluorescein diacetate (DCFDA)
Figure 6 Analysis of JNK1/2, p38 and ERK1/2 following Dia treatment in Wt
and G6pdD ES cells. Wt and G6pdD ES cells were incubated for 30 min with the
indicated amount of Dia. Total cell lysates were prepared and analysed by
Western blotting using antibodies against the phosphorylated forms of JNK1/2,
p38 and ERK1/2. The analysis of actin content was used as a loading control
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The pattern of ERK activation suggested a possible role for
this kinase in the induction of apoptosis. To address this
hypothesis, we made use of U0126, an inhibitor of the
activation of the upstream kinase MEK, thus abolishing ERK
phosphorylation. Wt and G6pdD ES cells were treated with a
30 min Dia pulse at the doses known to induce apoptosis (see
above) in the presence or absence of the MEK inhibitor
U0126. Cells were then analysed either after 30 min, to detect
ERK phosphorylation, or after 8 h, to investigate PARP and
the caspase-3 cleavage status, as a marker for apoptotic cell
death. As shown in Figure 7a, treatment with U0126 while
completely inhibiting ERK phosphorylation in both cell lines,
had remarkably the opposite effect on apoptosis markers in wt
and G6pdDES cells. When we treated wt ES cells with a lethal
dose of Dia, in the presence of the MEK inhibitor, we could
reproducibly observe an increased amount of the faster
migrating PARP cleavage product, as well as an increase in
the amount of activated caspase 3, suggesting a role of MEK/
ERK in an antiapoptotic pathway. On the contrary, in G6pdD
ES cells, the presence of U0126 strongly decreased the level
of activated caspase-3 and cleavage of PARP, as well as the
release of cytochrome c from mitochondria and the activation
of caspase-9 (Figure 7b), suggesting an active role for the
MEK/ERK pathway in mediating the apoptotic effect of Dia.
These results, therefore, show that MEK/ERK activation
plays a proapoptotic role in the G6pdD ES cells, while in the wt
cell lines, ERK activation is either insufficient or possibly
implicated in an antiapoptotic response.
ERK activation has multiple roles in cell fate
decisions after Dia treatment
The observation that G6pdD ES cells activated different
MAPK pathways in response to oxidative stress with respect
to the parental wt ES cells was, in part, expected, given the
strong difference in apoptosis sensitivity of the two cell lines.
The results shown in Figure 7, though, suggest that the
absence of G6PD does not simply lower the threshold for
oxidative stress sensitivity. Diamide concentrations that
induce apoptotic cell death in wt and G6pdD ES cells with
similar kinetics (data not shown) activate the same pathway
with opposite outputs. One possibility, to explain this apparent
discrepancy, is that a change in GSH/GSSG ratio is sensed by
the MEK/ERK pathway in ES cells and that the effect of this
activation, in terms of life or death for the cell, could then
depend on the persistence of the stress as well as from the
intensity. We have already shown15 that after 30 min of Dia
treatment, most of the cellular GSH is converted to GSSG. To
investigate whether stress persistence might play a role in the
output of MEK/ERK activation, we treated G6pdD ES cells
with shorter pulses of 150mM Dia. As shown in Figure 8 (lanes
1 and 2), a 10 min Dia pulse was already able to induce
caspase-3 activation and PARP cleavage in G6pdD ES cells.
Strikingly, when we analysed the role of the MEK/ERK
pathway by treating the cells with U0126 during the two
different Dia pulses (Figure 8, compare lanes 2/3 and 4/5), we
observed that U0126 treatment increased the level of
caspase-3 activation at the 10 min incubation time and
inverted its effect to an inhibitor of caspase-3 activation, as
already shown in Figure 7, at the 30 min incubation time point,
suggesting that ES cells try to rescue the death induced by the
change in GSH/GSSG ratio by activating an MEK/ERK-
dependent survival pathway, but if the GSH oxidation persist,
they convert the MEK/ERK-dependent survival pathway into a
proapoptotic one.
Diamide treatment induces the formation of GSSG
in G6pdD but not in wt ES cells
The results shown in Figures 6 and 7 suggest that, although
800 and 150mM Dia kill wt and G6pdD ES cells with similar
kinetics, respectively, they probably induce cell death through
different signal transduction pathways. This difference could
Figure 7 Inhibition of Dia-induced ERK activation has different outputs in wt
and G6pdD ES cells. (a) The effect of the MEK inhibitor U0126 was analysed on
the apoptosis induced by 800 and 150 mM Dia on wt and G6pdD ES cells,
respectively. Cells were treated for 30 min with the indicated Dia concentrations
in the presence or absence of the MEK inhibitor U0126 and, either harvested
immediately, to measure the phosphorylation status of ERK, or collected after 8 h
to measure the cleavage status of PARP and caspase-3. The figure is a Western
blot analysis using antibodies specific for the phosphorylated form of ERK, for
PARP or for the cleaved form of caspase-3. (b) G6pdD ES cells were harvested
4 h after Dia treatment in the presence or absence of U0126, and cytosolic
extracts were analysed by Western blot for the presence of cytochrome c or for
the cleavage of caspase-9
Figure 8 Inhibition of Dia-induced ERK activation in G6pdD ES cells has
different outputs, depending on the duration of the stress. The effect of the MEK
inhibitor U0126 was analysed on the apoptosis induced by 150 mM Dia on
G6pdD ES cells. Cells were treated for 10 and 30 min with 150mM Dia in the
presence or absence of the MEK inhibitor U0126 and collected after 8 h to
measure the cleavage status of PARP and caspase-3. The figure is a Western
blot analysis using antibodies specific for PARP or for the cleaved form of
caspase-3
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reflect a difference in the amount of GSH oxidised or in its
oxidation rate in wt and G6pdD ES cells treated with the
respective lethal doses of Dia. We therefore measured the
kinetics of GSH decrease and GSSG appearance in wt and
G6pdD ES cells upon incubation with 800 and 150 mM Dia,
respectively. As shown in Figure 9, after 10 min of Dia
incubation there was already a dramatic drop in the GSH cell
content both in wt ES cells treated with 800mM Dia and in
G6pdD ES cells treated with 150mM Dia, although the level of
decrease was much more pronounced in the cells devoid of
G6PD activity. Analysis of GSSG cell content during the time
after Dia treatment also revealed a very different picture
between wt and G6pdDES cells: we were unable to detect any
traces of GSSG in wt ES cells even after 30 min of incubation
with 800mM Dia. GSSG, instead, reached its maximum level
in G6pdD ES cells already after 10 min of 150 mM Dia
treatment, suggesting that the conditions of oxidative stress
induced in wt and G6pdD ES cells upon incubation with 800
and 150 mM Dia, respectively, have strongly different features.
Discussion
By targeting the gene coding for G6PD in mouse ES cells for
deletion, we have previously shown that the reducing potential
produced by G6PD in the form of NADPH is essential for an
efficient response to oxidant treatment. G6pd-deleted ES
cells fail to sustain high GSH levels when treated with low
levels of oxidating agents. In this paper, we analyse the
signalling events downstream of GSH oxidation in terms of
apoptosis and/or survival in G6pdD ES cells in comparison to
wt ES cells. Furthermore, we investigate if the condition of
oxidative stress that we observe at low oxidant concentrations
in G6pdD ES cells are equivalent to the oxidative stress
induced by high oxidant doses in ES cells wt for G6PD.
We have previously reported that G6pdD ES cells become
permeable to Trypan blue staining after treatment with Dia
doses otherwise sublethal for wt ES cells.15 Trypan blue
permeability could be the consequence either of apoptotic cell
death or necrotic cell death. It has been shown, in different cell
systems, that oxidant treatment, if not counterbalanced by an
appropriate antioxidant response, can induce either an
apoptotic pathway or necrosis. The decision between
apoptosis and necrosis is usually dictated by the strength of
the oxidative insult.18 Accordingly, we found that low doses of
Dia engage an apoptotic pathway in G6pdD ES cells, as
measured by the appearance of the cleaved forms of
caspase-3 and PARP. By increasing the Dia concentration
over 300mM, all cells became Trypan blue positive without
caspase-3 activation, a condition that is characteristic of
necrotic cell death. Interestingly, at these Dia concentrations,
the control wt ES cells did not show any signs of caspase-3
activation or permeability to Trypan blue. To induce a similar
level of caspase-3 activation in wt ES cells, it was necessary
to increase Dia concentration up to eight times more. This
increased sensitivity of G6pd-deleted ES cells against the
effect of Dia is likely due to the redox imbalance that we
previously observed in these cells, characterised by low GSH
and low NADPH content, because the effect can be reversed
by treating the cells with the GSH precursor, NAC.
The establishment of a condition of redox imbalance was
followed by destabilisation of the outer mitochondrial perme-
ability that presumably rapidly triggered the apoptotic path-
way. We could indeed completely block caspases activation
by overexpressing the antiapoptotic protein Bcl-XL in G6pdD
ES cells. On the other hand, Bcl-XL expression prevented
ROS formation following Dia treatment only to a very small
extent (Figure 5), suggesting a role in blocking the apoptotic
signal transduction pathway rather than in preventing oxida-
tive stress. In line with this, also the decrease in GSH levels
and ERK activation (see below) was not influenced by Bcl-XL
expression (data not shown). If Bcl-XL expression does not
prevent oxidative stress, but only the activation of the
apoptotic pathway, this would imply that life is compatible
with a certain amount of oxidation of cellular structures.
Otherwise Bcl-XL expression, similar to what has been
observed with Bcl-2,19 might play a role also as an antioxidant,
by blocking the damaging effects of peroxides, rather than
preventing their formation.
Although a possible involvement of G6PD in the protection
from apoptosis was previously indirectly suggested by the use
of the G6PD inhibitors dehydroepiandrosterone and 6-
aminonicotinamide,20 to our knowledge for the first time a
role for G6PD in the protection from redox imbalance-induced
apoptosis and necrosis has been clearly assigned, also in
view of the complex and multiple physiological effects
triggered by these inhibitors.21 That G6PD could be a
mediator of a survival pathway was also previously suggested
by the fact that G6PD overexpression in HeLa cells increased
their resistance to H2O2 and TNFa treatment.
22
G6PD is not the only NADPH-producing enzyme in
nucleated cells, although we have previously shown that it is
the only one strongly activated by oxidant treatment.
Probably, the peculiarity of G6PD lies in the fact that it uses
a highly abundant and readily available source of reducing
power, glucose, and this makes it the rate-limiting factor in
antioxidant defence. This should be taken into account when
considering the importance of glucose in cell survival. In the
absence of glucose, in fact, cells are not only unable to
proceed through the glycolytic pathway but they are also
affected in the production of the main reducing equivalent,
Figure 9 Contrary to what was observed in G6pdD ES cells, GSH decrease in
Dia-treated wt ES cells is not accompanied by a GSSG increase. Wt and G6pdD
ES cells were treated for the indicated amount of time with 800 and 150 mM Dia,
respectively. After acidic extraction, changes in cellular GSH and GSSG content
were analysed by HPLC
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NADPH. For instance, the oncogene Akt has a broad
antiapoptotic activity but, different from Bcl-XL, strictly
requires glucose availability to afford protection against
apoptosis.23,24 It has been suggested that glucose phosphor-
ylation is sufficient to promote cell survival by Akt, based on
the fact that 2-deoxyglucose, a glucose analogue that can be
phosphorylated by hexokinase but not further metabolised
through the glycolytic pathway, restores Akt ability to prevent
apoptosis.23. Given the importance for G6PD activity in cell
survival and given that 2-deoxyglucose-6-phosphate,
although not further metabolised during glycolysis, is ac-
cepted as a substrate by G6PD,25 we propose that the strict
glucose requirement of Akt-induced survival could depend on
the activity of the PPP shunt.
Although G6PD seems to have a central role in protection
from apoptosis, this effect seems to be specific for apoptosis
induced by oxidating agents. G6pd-deleted ES cells
were equally sensitive to Chx-induced cell death (Figure 3)
and serum starvation (data not shown), and even slightly
more resistant to the death induced by UV irradiation or
CisPt. On the other hand, G6PD-deleted cells showed
increased sensitivity to agents inducing, directly or indirectly,
ROS, and ROS production has been suggested to be
and intermediated in several apoptotic pathways.4 It
will be interesting to investigate if G6pd-deleted cells could
also be sensitive to conditions accompanied by physiological
levels of intracellular ROS production, as it has been
suggested to occur during TNFa treatment or prolonged p53
activation.26–28 We are currently deriving an epithelial-like cell
line from in vitro differentiated ES cells to address this
possibility.
In order to study the signal transduction pathway activated
by Dia-induced oxidative stress in ES cells deleted or not of
the G6pd gene, we investigated the phosphorylation status of
the major cellular MAPK pathways. The pathway that mirrored
most closely the difference in oxidative stress sensitivity found
in wt and G6pdD ES cells was the MEK/ERK pathway.
Interestingly, MEK/ERK activation seemed to have a multiple
role in ES cells’ fate decisions: in G6pdDES cells, it seemed to
have a protective role following a very short pulse of oxidant
treatment, and clearly a proapoptotic function following a
longer oxidant exposure. In wt ES cells, on the contrary, MEK/
ERK activation seemed to have a protective role in all the
conditions tested. Independent of its role in apoptosis
induction, our data clearly indicate that in ES cells the
establishment of a condition of redox imbalance is sensed
by the MEK/ERK pathway. Although JNK and p38 were also
activated at different oxidant concentrations in wt and G6pdD
ES cells, their activation was transient and did not correlate
with redox imbalance and apoptosis induction. We observed,
in fact, JNK and p38 activation in wt ES cells treated with
100mM Dia, a condition that does not induce apoptosis
(Figure 1). How does oxidative stress activate MEK/ERK?
According to a previously reported study, a possible explana-
tion involves the inactivation, through disulphide bonds
formation, of receptor tyrosine phosphatases. These keep
normally the activation level of receptor tyrosine kinases low,
following prolonged stimulation by receptor ligands. Transient
inactivation of the phosphatases results therefore in transient
activation of the kinases receptor.29 Receptor tyrosine
kinases are among the strongest activators of the MEK/ERK
pathway. Indeed, we have preliminary results showing a
general increase in phosphotyrosines following Dia treatment
(data not shown).
As mentioned above, MEK/ERK activation produces
opposite outputs, depending on the persistence of the stress
and on the G6PD status of the cells. The fact that a 10 min
pulse of 150mM Dia in G6pdD ES cells results in the activation
of the pathway with an apparent antiapoptotic function
(Figure 8) resembled the condition that we observed in wt
ES cells when treated for 30 min with 800 mM Dia (Figure 7).
This was initially suggesting that, if there was simply a
threshold difference between wt and G6pdDES cells, this was
higher than initially thought, and also dependent on the
oxidant exposure time. It would be possible to extrapolate
from this argument that in wt ES cells treated for a longer time
or with a higher Dia dose, the activation of the MEK/ERK
pathway would become proapoptotic as well. We were unable
to confirm this prediction because of the necrotic effect that
Dia has at higher concentrations and exposure times (data not
shown). This observation highlights the difference in oxidant
sensitivity between wt and G6pdD ES cells. This difference
became even more evident when we measured the kinetics of
GSH decrease after treating wt and G6pdD ES cells with their
respective lethal dose of oxidant. We found that not only was
there a difference in the kinetics of GSH decrease between
the two cell lines, but, while the GSH decrease was
accompanied by an increase in GSSG level in G6pdD ES
cells, we could not observe any traces of GSSG in wt cells
following oxidant treatment. It is possible to speculate that
Dia-treated wt ES cells might use protein thiols instead of a
second molecule of GSH as an electron donor and might
result in an increased cellular content of glutathionylated
proteins,30,31 more than GSSG. This observation suggests
that we cannot explain the difference in oxidant sensitivity of
wt and G6pdD ES cells with a simple threshold model, but we
have to consider the conditions of oxidative stress induced by
Dia in ES cells, in the presence or absence of a G6PD activity,
qualitatively very different.
The results presented in this paper indicate G6PD as one of
the major enzymes involved in cell survival following redox
imbalance, and a key player in cellular antioxidant defence. In
addition, these findings could be particularly relevant in
relation to the fact that G6PD deficiency is one of the most
common enzymopathies in the human population.32,33 As the
establishment of a condition of oxidative stress has been
implicated as the main cause of several degenerative
diseases, including neurodegenerative disorders, like Parkin-
son and Alzheimer,7 the genesis of type II diabetes,8 heart
failure and stroke,9 it will be of great interest to study possible
connections between the risk of progression of such diseases
and inherited G6PD deficiency.
Materials and Methods
Reagents and cell culture
NAC, GSH, Mq, Dia, Chx, CisPt and Gox were purchased from Sigma-
Aldrich. U0126 was from Promega. Antibodies specific for PARP, cleaved
caspase-3 (Asp175), caspase-9, phospho-SAPK/JNK (Thr183/Tyr185),
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phospho-p38 MAP kinase (Thr180/Tyr182) and phospho-p44/42 MAP
kinase (Thr202/Tyr204) (phospho-ERK1/2) were purchased from New
England Biolabs. Antibodies specific for cytochrome c were from BD
Biosciences (clone 7H8.2C12). ES cells were cultured on mouse
fibroblasts as described by Robertson.34
Cell death assay
At 48 h before treatment, cells were seeded at equal density on gelatin-
coated plates. Cells were treated either with Dia, Mq, Gox or Chx for
30 min and than harvested after 8 h, or with CisPt for 16 h, or they were UV
irradiated at 10 mJ/cm2 using a Stratalinker 2400 (Stratagene) and
collected after 8 h. Where NAC or U0126 was used, cells were first
preincubated for 30 min and then treated as indicated in the presence of
the same concentration of the NAC or U0126. For apoptosis assay, cell
extracts were either analysed by Western blotting for PARP and caspase-
3 cleavage or using the commercial kit Cell Death Elisa (Roche).
Western blotting
Total cell lysates were prepared from cells grown on gelatin-coated plates.
Cells were lysed in 10 mM Tris-HCl pH7.4, 150 mM NaCl, 1 mM EDTA, 1%
Triton X-100, 10% glycerol, supplemented with 0.5 mM DTT, 0.5 mM
phenylmethylsulphonyl fluoride, 2 mM benzamidine, 20 mg/ml aprotinin,
4 mg/ml pepstatin, 10 mM leupeptin, 10 mM sodium fluoride, 1 mM sodium
orthovanadate and 25 mM b-glycerophosphate (Sigma-Aldrich). After
15 min incubation on ice, the lysates were cleared by centrifugation. Total
cell extracts were separated on 10% or 12.5% SDS-PAGE and transferred
to Immobilon-P transfer membranes (Millipore). After blocking with 5%
nonfat milk, membranes were incubated with primary antibodies as
recommended by the supplier. The immune complexes were detected by
the ECL detection system according to the manufacturer’s protocol
(Amersham Bioscience).
Detection of cytochrome c release
To evaluate the amount of cytochrome c released into cytosol, cells were
trypsinised, washed in PBS and resuspended in 300 ml of isotonic-sucrose
buffer (20 mM HEPES/NaOH pH 7.3, 250 mM sucrose, 1.5 mM MgCl2,
10 mM KCl, 1 mM EDTA, 1 mM DTT and 1 CompleteTM (Roche))
containing 5 mg of digitonin/4 106 cells. After incubation for 3 min at
room temperature, cells were centrifuged at 9500 g for 5 min at 41C.
The resulting supernatant was then separated on 12.5% SDS-PAGE, and
analysed by Western blotting using a monoclonal antibody specific for
cytochrome c.
Generation of G6pd and Bcl-XL overexpressing ES
cells
For the generation of G6pd and Bcl-XL ES cells, the wt and G6pdD ES cell
lines were electroporated with 20mg of linearised plasmid vector Pallino b-
actin G6pd or Pallino b-actin Bcl-XL, a plasmid vector containing,
respectively, G6pd or Bcl-XL cDNA driven by b-actin promoter, and the
puromycin-resistance gene driven by the mouse phosphoglycerokinase
promoter. Transfected clones were selected by growth in the presence of
puromycin 1 mg/ml, and the resistant clones were subjected to immunoblot
analysis by using anti-rabbit-G6PD antibody (ABCAM) or anti-mouse-Bcl-
XL antibody (BD Biosciences).
Fluorescent measurement of intracellular ROSs
For the fluorimetric measure of ROS, cells were trypsinised and washed
three times with PBS; 1 106 cells were suspended in 2 ml of PBS and
incubated with 10 mM 6-carboxy-20,70-dichlorodihydrofluorescein diace-
tate, di(acetoxymethyl ester) (DCHF-DA) (Molecular Probes), for 20 min at
371C. Then, the cells were washed twice with PBS, suspended in 2 ml of
PBS and fluorescence levels were measured using a spectrofluorimeter
(FP-777 Jasco) with excitation and emission wavelengths set at 495 and
530 nm, respectively.
GSH and GSSG measurements
To determine intracellular levels of oxidised and reduced glutathione
(GSH), acidic extracts from cells untreated or treated as described in
Figure 9 were subjected to reversed-phase high-performance liquid
chromatography using an electrochemical detection system (HPLC/ECD)
as described.15
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